FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025657706> ?p ?o ?g. }

• W3025657706 endingPage "3306" @default.
• W3025657706 startingPage "3296" @default.
• W3025657706 abstract "Objective: Neutropenia is an adverse event commonly arising during intensive chemotherapy of acute myeloid leukemia (AML). It is often associated with infectious complications. Mathematical modeling, simulation, and optimization of the treatment process would be a valuable tool to support clinical decision making, potentially resulting in less severe side effects and deeper remissions. However, until now, there has been no validated mathematical model available to simulate the effect of chemotherapy treatment on white blood cell (WBC) counts and leukemic cells simultaneously. Methods: We developed a population pharmacokinetic/pharmacodynamic (PK/PD) model combining a myelosuppression model considering endogenous granulocyte-colony stimulating factor (G-CSF), a PK model for cytarabine (Ara-C), a subcutaneous absorption model for exogenous G-CSF, and a two-compartment model for leukemic blasts. This model was fitted to data of 44 AML patients during consolidation therapy with a novel Ara-C plus G-CSF schedule from a phase II controlled clinical trial. Additionally, we were able to optimize treatment schedules with respect to disease progression, WBC nadirs, and the amount of Ara-C and G-CSF. Results: The developed PK/PD model provided good prediction accuracies and an interpretation of the interaction between WBCs, G-CSF, and blasts. For 14 patients (those with available bone marrow blast counts), we achieved a median 4.2-fold higher WBC count at nadir, which is the most critical time during consolidation therapy. The simulation results showed that relative bone marrow blast counts remained below the clinically important threshold of 5%, with a median of 60% reduction in Ara-C. Conclusion: These in silico findings demonstrate the benefits of optimized treatment schedules for AML patients. Significance: Until 2017, no new drug had been approved for the treatment of AML, fostering the optimal use of currently available drugs." @default.
• W3025657706 created "2020-05-21" @default.
• W3025657706 creator A5019526778 @default.
• W3025657706 creator A5019885844 @default.
• W3025657706 creator A5058914292 @default.
• W3025657706 creator A5069866186 @default.
• W3025657706 creator A5070436541 @default.
• W3025657706 creator A5089395073 @default.
• W3025657706 date "2020-12-01" @default.
• W3025657706 modified "2023-10-06" @default.
• W3025657706 title "Model-Based Optimal AML Consolidation Treatment" @default.
• W3025657706 cites W109252363 @default.
• W3025657706 cites W1823520599 @default.
• W3025657706 cites W1872114762 @default.
• W3025657706 cites W1964811286 @default.
• W3025657706 cites W1965420754 @default.
• W3025657706 cites W1993011379 @default.
• W3025657706 cites W1995101917 @default.
• W3025657706 cites W2000910321 @default.
• W3025657706 cites W2001791620 @default.
• W3025657706 cites W2009886857 @default.
• W3025657706 cites W2012899038 @default.
• W3025657706 cites W202042235 @default.
• W3025657706 cites W2022188151 @default.
• W3025657706 cites W2026736608 @default.
• W3025657706 cites W2026826794 @default.
• W3025657706 cites W2032414164 @default.
• W3025657706 cites W2032457412 @default.
• W3025657706 cites W2033745948 @default.
• W3025657706 cites W2033902902 @default.
• W3025657706 cites W2038639830 @default.
• W3025657706 cites W2040625016 @default.
• W3025657706 cites W2042134687 @default.
• W3025657706 cites W2048385227 @default.
• W3025657706 cites W2050061928 @default.
• W3025657706 cites W2065135146 @default.
• W3025657706 cites W2065899334 @default.
• W3025657706 cites W2068545549 @default.
• W3025657706 cites W2079035972 @default.
• W3025657706 cites W2082535104 @default.
• W3025657706 cites W2093448464 @default.
• W3025657706 cites W2103443944 @default.
• W3025657706 cites W2119897082 @default.
• W3025657706 cites W2120925536 @default.
• W3025657706 cites W2123871098 @default.
• W3025657706 cites W2131280878 @default.
• W3025657706 cites W2143647913 @default.
• W3025657706 cites W2161304688 @default.
• W3025657706 cites W2162731574 @default.
• W3025657706 cites W2169256688 @default.
• W3025657706 cites W2239946454 @default.
• W3025657706 cites W2318280343 @default.
• W3025657706 cites W2318674152 @default.
• W3025657706 cites W2534021178 @default.
• W3025657706 cites W2559537906 @default.
• W3025657706 cites W2588503193 @default.
• W3025657706 cites W2617245268 @default.
• W3025657706 cites W2621707007 @default.
• W3025657706 cites W2765126288 @default.
• W3025657706 cites W2775415556 @default.
• W3025657706 cites W2783339978 @default.
• W3025657706 cites W2783450169 @default.
• W3025657706 cites W2790604092 @default.
• W3025657706 cites W2805733506 @default.
• W3025657706 cites W2842089854 @default.
• W3025657706 cites W2885610455 @default.
• W3025657706 cites W2889920057 @default.
• W3025657706 cites W2912232420 @default.
• W3025657706 cites W2912466997 @default.
• W3025657706 cites W2953422532 @default.
• W3025657706 cites W2954868958 @default.
• W3025657706 cites W2975689185 @default.
• W3025657706 cites W2984994530 @default.
• W3025657706 cites W3048696092 @default.
• W3025657706 cites W4235623249 @default.
• W3025657706 doi "https://doi.org/10.1109/tbme.2020.2982749" @default.
• W3025657706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32406820" @default.
• W3025657706 hasPublicationYear "2020" @default.
• W3025657706 type Work @default.
• W3025657706 sameAs 3025657706 @default.
• W3025657706 citedByCount "7" @default.
• W3025657706 countsByYear W30256577062021 @default.
• W3025657706 countsByYear W30256577062022 @default.
• W3025657706 countsByYear W30256577062023 @default.
• W3025657706 crossrefType "journal-article" @default.
• W3025657706 hasAuthorship W3025657706A5019526778 @default.
• W3025657706 hasAuthorship W3025657706A5019885844 @default.
• W3025657706 hasAuthorship W3025657706A5058914292 @default.
• W3025657706 hasAuthorship W3025657706A5069866186 @default.
• W3025657706 hasAuthorship W3025657706A5070436541 @default.
• W3025657706 hasAuthorship W3025657706A5089395073 @default.
• W3025657706 hasBestOaLocation W30256577061 @default.
• W3025657706 hasConcept C111113717 @default.
• W3025657706 hasConcept C112705442 @default.
• W3025657706 hasConcept C126322002 @default.
• W3025657706 hasConcept C143998085 @default.
• W3025657706 hasConcept C197934379 @default.
• W3025657706 hasConcept C2776694085 @default.

• next